Veru's pivot with enobosarm: groundbreaking Phase 2b results enhance GLP-1 therapy outcomes. A positive launch could yield ...

A dysfunction in muscle blood vessels could be to blame for the weak muscles and weight loss that most cancer patients ...

A dysfunction in muscle blood vessels could be to blame for the weak muscles and weight loss that most cancer patients ...

While myostatin therapies have previously been studied for musculoskeletal disorders like spinal muscular atrophy ... of therapies for muscle loss, saying, “Is this [GLP-1 related muscle ...

Foods high in protein, fiber, and healthy fats can trigger the release of GLP-1, an important hormone that helps regulate blood sugar levels and promotes a feeling of fullness. Glucagon-like ...

Back to Healio The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial ...

The use of glucagon-like peptide 1 (GLP-1) medications amongst women – particularly those of childbearing age – has risen dramatically in recent years. From 2020 to 2023, the rate of young ...

As consumers are clamoring for access to pricey GLP-1 drugs for weight loss, employers are feeling the need to modify or update their plans to accommodate new demands and costs. KFF's 2024 Employer ...

Cigna is building on client demand for tools to support patients on GLP-1 weight loss drugs, announcing two new programs on Friday meant to improve clinical care around the dispensing of GLP-1s ...

insulin and 50,590 to compare GLP-1s and metformin. Singh noted he was particularly interested in potential associations between GLP-1 use and clonal hematopoiesis of indeterminate potential (CHIP ...